BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ishita Drugs & Industries Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524400
ISIN Demat
INE806D01016
Book Value (Rs)
38.6883488
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
21
P/E (TTM)
30.15
EPS (TTM)
2.36
Face Value
(Rs)
10
Back
Ishita Drugs & Industries standalone net profit declines 37.93% in the March 2026 quarter
01-Jun-26   Hrs IST

Net profit of Ishita Drugs & Industries declined 37.93% to Rs 0.18 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025. Sales declined 32.89% to Rs 3.06 crore in the quarter ended March 2026 as against Rs 4.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.34% to Rs 0.78 crore in the year ended March 2026 as against Rs 0.87 crore during the previous year ended March 2025. Sales declined 2.27% to Rs 14.66 crore in the year ended March 2026 as against Rs 15.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.064.56 -33 14.6615.00 -2
OPM %3.276.36 -5.256.67 -
PBDT0.300.41 -27 1.181.27 -7
PBT0.280.38 -26 1.081.16 -7
NP0.180.29 -38 0.780.87 -10

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)